Commentary: Histaminergic Drugs Could be Novel Targets for Neuroprotection in CNS Disorders

Publisher： Bentham Science Publishers

E-ISSN： 1996-3181|15|6|642-643

ISSN： 1871-5273

Source： CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol.15, Iss.6, 2016-07, pp. : 642-643

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Piracetam and Piracetam-Like Drugs: From Basic Science to Novel Clinical Applications to CNS Disorders

By Malykh Andrei G.   Sadaie M. Reza  

Drugs, Vol. 70, Iss. 3, 2010-02 ,pp. : 287-312

Adis International

Access to resources Recommend Favorite

Neuroprotection and Drugs Used to Treat Psychiatric Disorders

By  

Child and Adolescent Psychopharmacology News, Vol. 12, Iss. 4, 2007-08 ,pp. : 1-5

Guilford Publications Inc

Access to resources Recommend Favorite

Novel Targets for Drugs in Schizophrenia

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 6, Iss. 4, 2007-08 ,pp. : 265-272

Bentham Science Publishers

Access to resources Recommend Favorite

Adhesion Molecules in CNS Disorders: Biomarker and Therapeutic Targets

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 12, Iss. 3, 2013-05 ,pp. : 392-404

Bentham Science Publishers

Access to resources Recommend Favorite

Neurogenic Drugs and Compounds to Treat CNS Diseases and Disorders

By  

Central Nervous System Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Central Nervous System Agents), Vol. 11, Iss. 1, 2011-01 ,pp. : 35-37

Bentham Science Publishers

Access to resources Recommend Favorite